Amyloid beta pathology induces astrocytic pTDP-43 mislocalization and disrupts TDP-43-regulated cryptic exon transcripts.

Background: While amyloid-β (Aβ) and tau are hallmark pathologies of Alzheimer's disease (AD), TDP-43 proteinopathy is increasingly recognized as an important contributor, occurring in up to 57% of AD cases and associated with accelerated cognitive decline. TDP-43 regulates RNA splicing, and its mis...

Descripción completa

Detalles Bibliográficos
Publicado en:Frontiers in Aging Neuroscience pp. 1 - 12
Autores principales: Rafiee, Zeinab, Santiago, Jessica, Andersson, Emelie, Hansson, Oskar, Wennström, Malin
Formato: research tables/charts Journal Article
Publicado: Frontiers Media S.A. 2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=193361836&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 193361836
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        16634365
        BG2U
      jtl: Frontiers in Aging Neuroscience
      issn: 16634365
      maglogo: N
    pubinfo:
      dt: 2026
      pid: 40038
      pub: Frontiers Media S.A.
    artinfo:
      ui:
        193361836
        193361836
        193361836
        10.3389/fnagi.2026.1766448
        193361836
      ppf: 1
      ppct: 11
      formats:
      tig:
        atl: Amyloid beta pathology induces astrocytic pTDP-43 mislocalization and disrupts TDP-43-regulated cryptic exon transcripts.
      aug:
        au:
          Rafiee, Zeinab
          Santiago, Jessica
          Andersson, Emelie
          Hansson, Oskar
          Wennström, Malin
        affil: Cognitive Disorder Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
      sug:
        subj:
          Amyloid beta-Peptides Adverse Effects
          TDP-43 Proteinopathies Metabolism
          Animal Studies
          Funding Source
          Mice
          In Vitro Studies
          Cell Culture Techniques
          Descriptive Statistics
          Immunohistochemistry
          Gene Expression
          Data Analysis Software
          One-Way Analysis of Variance
          Post Hoc Analysis
          Mann-Whitney U Test
          RNA
      ab: Background: While amyloid-β (Aβ) and tau are hallmark pathologies of Alzheimer's disease (AD), TDP-43 proteinopathy is increasingly recognized as an important contributor, occurring in up to 57% of AD cases and associated with accelerated cognitive decline. TDP-43 regulates RNA splicing, and its mislocalization leads to cryptic exon inclusion and loss of canonical protein function. While neuronal TDP-43 pathology has been well studied, its role in astrocytes remains less understood. Recent findings suggest increased phosphorylated TDP-43 (pTDP-43) inclusions in astrocytic endfeet in AD and a bidirectional interaction between Aβ and TDP-43, promoting mutual aggregation. Methods: We analyzed pTDP-43 immunoreactivity (IR) in astrocytic perivascular end-feet, nuclei, and cytosol in hippocampal sections from 3-month-old and 18-month-old AppNL–F/NL–F mice and 18-month-old wild-type controls using ImageJ. In vitro , primary fetal human astrocytes were exposed to oligomeric Aβ42, and changes in cytosolic and nuclear pTDP-43 IR were quantified via ImageJ, while TDP-43 and pTDP-43 protein levels were measured using an in-house ELISA. Expression of canonical transcripts ATG4B and KALRN, involved in autophagy and synaptic support, was assessed by qPCR. Corresponding protein-level changes were evaluated using in-house ELISA. Results: Our findings demonstrate significantly higher pTDP-43 accumulations in astrocytic nuclei, cytosol, and endfeet in 18-month-old AppNL–F/NL–F mice compared to age-matched wild-type mice. Astrocytes exposed to oligomeric Aβ42 showed elevated cytosolic pTDP-43 IR and total pTDP-43 protein levels. Concurrently, expression of canonical ATG4B and KALRN transcripts was significantly reduced, which was accompanied by corresponding decreases in protein levels. Conclusion: Our findings demonstrate that pTDP-43 accumulates in astrocytic nuclei, cytosol, and endfeet in the presence of AD pathology. The observed Aβ-induced increase in cytosolic pTDP-43 and transcript disruption suggests a mechanistic link contributing to autophagy impairment and cytoskeletal changes in astrocytes, potentially exacerbating AD progression.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N